Whole–genome characterization of chemoresistant ovarian cancerAnn‐Marie Patch, Suzanne Manning, Elizabeth L. Christie et al.|Nature|2015Cited by 1.7k
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian CancerEllen L. Goode, Naveena Singh, Matthew S. Block et al.|JAMA Oncology|2017Cited by 409
The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Goli Samimi, Matthew J. Wakefield et al.|Nature Communications|2019Cited by 191
Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i> -Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic DriverCatherine Emmanuel, Anna DeFazio, Yoke-Eng Chiew et al.|Clinical Cancer Research|2014Cited by 119
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancerDale W. Garsed, David D.L. Bowtell, Ahwan Pandey et al.|Nature Genetics|2022Cited by 115